Skip to main content
Premium Trial:

Request an Annual Quote

Decode Stock to Return to Nasdaq Global Market

NEW YORK (GenomeWeb News) – Decode Genetics today said that its stock will be returned to the Nasdaq Global Market at the opening of trade on Monday, June 29.

The firm said that the reinstatement follows the Nasdaq Hearing and Listing Review Council's decision to reverse a February decision by the Listing Qualifications Panel to transfer Decode's stock to the Nasdaq Capital Market. Decode did not specify the reasons why its stock would be transferred back to the Global Market.

Just a few months ago, Decode's stock was in danger of being delisted from the Nasdaq Capital Market. The firm received a reprieve while the Nasdaq Listing and Hearing Review Council conducted a review and it continued to trade on that market.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.